COX-2–Selective NSAIDs With DOACs in Atrial Fibrillation—Analgesic Safety via Antithrombotic Stewardship

JAMA Network Open 2026 Open access

Read full text

Authors: Kelly Rudd, Geoffrey D. Barnes

DOI: 10.1001/jamanetworkopen.2026.13952

Cited by: 1

References: 5

Fields of Study & Subjects

Inflammatory mediators and NSAID effects Atrial Fibrillation Management and Outcomes Antiplatelet Therapy and Cardiovascular Diseases

References 5